The Most Effective Treatment We Have
Medication-assisted treatment (MAT) — using medications like buprenorphine or methadone alongside counseling to treat opioid use disorder — has the strongest evidence base of any approach to this condition, with studies consistently showing dramatic reductions in overdose death and improved retention in treatment compared to non-medication approaches. Despite this robust evidence, stigma and misunderstanding continue to limit access and acceptance of what is genuinely the gold-standard treatment.
Why Medications Work Better Than Willpower Alone
Opioid use disorder involves profound changes to brain chemistry and reward circuitry that make recovery through willpower or counseling alone extremely difficult for most people, similar to how other chronic medical conditions are not resolved by willpower alone. Medications like buprenorphine and methadone work by stabilizing the same brain receptors that opioids affect, reducing cravings and withdrawal without producing the impairment or dangerous cycle of intoxication and withdrawal that illicit opioid use involves.
Addressing the Stigma Gap
A persistent misconception frames MAT as merely substituting one addiction for another, but this misunderstands the pharmacology and the evidence — patients on appropriate MAT function normally, hold jobs, and are dramatically less likely to die of overdose than those attempting abstinence-only approaches. Expanding access to MAT, reducing regulatory and stigma-related barriers to prescribing and receiving it, represents one of the most impactful available interventions against the ongoing overdose crisis. Facilities can source pharmacy supplies and patient care supplies from our catalog.
